HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,040.00
-60.00 (-1.94%)
Aug 29, 2025, 12:39 PM KST

HLB Therapeutics Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Other Revenue
0--0-0--
Upgrade
61,23454,93252,59142,40343,58642,930
Upgrade
Revenue Growth (YoY)
3.54%4.45%24.03%-2.72%1.53%-27.20%
Upgrade
Cost of Revenue
50,57744,95345,40633,68238,57936,464
Upgrade
Gross Profit
10,6569,9797,1848,7215,0076,466
Upgrade
Selling, General & Admin
13,36816,19215,23615,67315,64115,786
Upgrade
Other Operating Expenses
265.66301.46183273.11240.04218.66
Upgrade
Operating Expenses
14,71017,60316,05316,22816,09417,732
Upgrade
Operating Income
-4,054-7,624-8,869-7,507-11,087-11,267
Upgrade
Interest Expense
-2,169-1,964-1,112-5,146-1,160-4,254
Upgrade
Interest & Investment Income
867.74984.551,1661,23096.09217.24
Upgrade
Earnings From Equity Investments
-5,594-3,153802.4---909.06
Upgrade
Currency Exchange Gain (Loss)
215.094,48294.65327.0397.78-86.81
Upgrade
Other Non Operating Income (Expenses)
0.681,363-3,430-1,33415.885.87
Upgrade
EBT Excluding Unusual Items
-10,734-5,912-11,347-12,430-12,038-16,294
Upgrade
Gain (Loss) on Sale of Investments
7,528-8,9587,7541,879-359.4813.53
Upgrade
Gain (Loss) on Sale of Assets
255.02-17.694.04-598.18-14.84.18
Upgrade
Asset Writedown
-2,242-8,037--424.08-4,632-1,953
Upgrade
Other Unusual Items
--624.11--720.83829.12
Upgrade
Pretax Income
-5,192-22,926-2,965-11,573-17,764-17,401
Upgrade
Income Tax Expense
263.25-----
Upgrade
Earnings From Continuing Operations
-5,456-22,926-2,965-11,573-17,764-17,401
Upgrade
Earnings From Discontinued Operations
0.69-534.08-113.98-530.86--
Upgrade
Net Income to Company
-5,455-23,460-3,079-12,104-17,764-17,401
Upgrade
Minority Interest in Earnings
380.62666.96777.16750.45567.08498.15
Upgrade
Net Income
-5,074-22,793-2,302-11,354-17,197-16,902
Upgrade
Net Income to Common
-5,074-22,793-2,302-11,354-17,197-16,902
Upgrade
Shares Outstanding (Basic)
848378686157
Upgrade
Shares Outstanding (Diluted)
848378686157
Upgrade
Shares Change (YoY)
6.04%6.36%14.46%10.86%7.26%4.63%
Upgrade
EPS (Basic)
-60.12-275.17-29.56-166.86-280.19-295.37
Upgrade
EPS (Diluted)
-60.12-275.17-29.56-166.86-280.19-295.37
Upgrade
Free Cash Flow
-2,958650.793,025-12,204-12,091-11,736
Upgrade
Free Cash Flow Per Share
-35.047.8638.84-179.37-196.99-205.09
Upgrade
Gross Margin
17.40%18.17%13.66%20.57%11.49%15.06%
Upgrade
Operating Margin
-6.62%-13.88%-16.86%-17.70%-25.44%-26.24%
Upgrade
Profit Margin
-8.29%-41.49%-4.38%-26.78%-39.45%-39.37%
Upgrade
Free Cash Flow Margin
-4.83%1.19%5.75%-28.78%-27.74%-27.34%
Upgrade
EBITDA
3,541467.85-389.34-5,841-9,386-10,566
Upgrade
EBITDA Margin
5.78%0.85%-0.74%-13.78%-21.54%-24.61%
Upgrade
D&A For EBITDA
7,5958,0928,4791,6661,701700.54
Upgrade
EBIT
-4,054-7,624-8,869-7,507-11,087-11,267
Upgrade
EBIT Margin
-6.62%-13.88%-16.86%-17.70%-25.44%-26.24%
Upgrade
Advertising Expenses
-0.69-0.217.0732.42
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.